Workflow
BigBear.ai(BBAI) - 2024 Q3 - Quarterly Report
BBAIBigBear.ai(BBAI)2024-11-07 21:28

Revenue and Gross Margin - Revenue increased by 7.5million(22.17.5 million (22.1%) in Q3 2024 compared to Q3 2023, driven by the Pangiam Acquisition, partially offset by decreased volumes in certain Air Force programs[172] - Gross margin for Q3 2024 was 10.8 million, up from 8.4millioninQ32023[171]Revenuesdecreasedby8.4 million in Q3 2023[171] - Revenues decreased by 0.2 million (0.2%) for the nine months ended September 30, 2024, compared to the same period in 2023, driven by the Pangiam Acquisition offset by decreased volume from the Air Force EPASS program[185] Operating and Net Loss - Operating loss for Q3 2024 was 10.5million,comparedto10.5 million, compared to 8.2 million in Q3 2023[171] - Net loss for Q3 2024 was 12.2million,comparedtoanetincomeof12.2 million, compared to a net income of 4.0 million in Q3 2023[171] - Adjusted EBITDA for the nine months ended September 30, 2024, was (4.358)million,comparedto(4.358) million, compared to (6.870) million in the same period in 2023[199] Acquisition and Strategic Initiatives - The company completed the acquisition of Pangiam on February 29, 2024, enhancing its vision and edge AI portfolio[150] - Transaction expenses decreased by 1.4million(100.01.4 million (100.0%) for the three months ended September 30, 2024, compared to the same period in 2023, due to the completion of the Pangiam Acquisition[178] - Research and development expenses increased by 5.5 million (183.9%) for the nine months ended September 30, 2024, compared to the same period in 2023, driven by increased headcount and the inclusion of Pangiam's results[188] Financial Performance and Expenses - Cost of revenues decreased to 74% of total revenues for the three months ended September 30, 2024, compared to 75% in the same period in 2023, driven by a higher mix of higher margin solutions[174] - SG&A expenses as a percentage of total revenues decreased to 42% for the three months ended September 30, 2024, compared to 46% in the same period in 2023, primarily due to higher revenue[175] - SG&A expenses as a percentage of total revenues increased to 51% for the nine months ended September 30, 2024, compared to 46% in the same period in 2023, driven by non-recurring strategic initiatives and integration costs[187] - Research and development expenses increased by 4.2million(1194.64.2 million (1194.6%) for the three months ended September 30, 2024, driven by increased headcount and timing of certain projects[176] Backlog and Contract Delays - Total backlog as of September 30, 2024, was 437.494 million, a significant increase from 167.810millionasofDecember31,2023[209]FundedbacklogasofSeptember30,2024,was167.810 million as of December 31, 2023[209] - Funded backlog as of September 30, 2024, was 77.422 million, compared to 30.112millionasofDecember31,2023[209]ThecompanyanticipatespotentialdelaysinnewcontractawardsduetothecontinuingresolutionfundingtheU.S.governmentthroughDecember20,2024[156]GeopoliticaltensionsinUkraine,theMiddleEast,andthePacificregionhaveslowedthepaceofcontractawards,pushingrevenueintosubsequentperiods[159]LiquidityandFinancingThecompanyraised30.112 million as of December 31, 2023[209] - The company anticipates potential delays in new contract awards due to the continuing resolution funding the U.S. government through December 20, 2024[156] - Geopolitical tensions in Ukraine, the Middle East, and the Pacific region have slowed the pace of contract awards, pushing revenue into subsequent periods[159] Liquidity and Financing - The company raised 20.6 million through the exercise of RDO warrants and 33.2millionthroughtheexerciseofPIPEwarrantsinearly2024[151][152]ThecompanyenteredintoaControlledEquityOfferingsalesagreementonMay10,2024,allowingittosellupto33.2 million through the exercise of PIPE warrants in early 2024[151][152] - The company entered into a Controlled Equity Offering sales agreement on May 10, 2024, allowing it to sell up to 150.0 million in common stock[213] - The company's primary sources of liquidity are cash flows from operations and access to credit facilities, with projected cash flow expected to meet needs for the next 12 months[210] - Available cash and cash equivalents increased to 65.584millionasofSeptember30,2024,comparedto65.584 million as of September 30, 2024, compared to 32.557 million as of December 31, 2023[217] - Net cash used in operating activities was 23.3millionfortheninemonthsendedSeptember30,2024,primarilyduetoanetlossof23.3 million for the nine months ended September 30, 2024, primarily due to a net loss of 22.2 million and unfavorable changes in net working capital[232] - Net cash provided by investing activities was 6.2millionfortheninemonthsendedSeptember30,2024,primarilyfromcashacquiredinthePangiamAcquisition[234]Netcashprovidedbyfinancingactivitieswas6.2 million for the nine months ended September 30, 2024, primarily from cash acquired in the Pangiam Acquisition[234] - Net cash provided by financing activities was 50.2 million for the nine months ended September 30, 2024, mainly from the exercise of PIPE and RDO warrants[235] - The Company entered into warrant exercise agreements, raising approximately 53.8millionfromtheexerciseofPIPEandRDOwarrants[229][230]DebtandConvertibleNotesTotaldebtremainedat53.8 million from the exercise of PIPE and RDO warrants[229][230] Debt and Convertible Notes - Total debt remained at 200.0 million as of September 30, 2024, with unamortized issuance costs of 4.262million[218][221]TheCompanyissued4.262 million[218][221] - The Company issued 200.0 million of unsecured convertible notes with a 6.0% annual interest rate, convertible into 18,844,600 shares of common stock[219][220] - The Company has a 25.0millionseniorsecuredrevolvingcreditfacilitywithBankofAmerica,maturingonDecember7,2025[222][223]TheCompanyslongtermdebt,netofunamortizedissuancecosts,was25.0 million senior secured revolving credit facility with Bank of America, maturing on December 7, 2025[222][223] - The Company's long-term debt, net of unamortized issuance costs, was 195.738 million as of September 30, 2024[218] - The conversion rate for the Convertible Notes was adjusted to 94.2230 shares per 1,000principalamountduetotheaveragedailyvolumeweightedaveragepriceofthecommonstockbeinglessthan1,000 principal amount due to the average daily volume-weighted average price of the common stock being less than 10.00 during the preceding 30 trading days[245] - The adjusted conversion price is 10.61,andtheConvertibleNotesareconvertibleinto18,844,600shares,excludinginterestpaymentssettledwithshares[245]TheoutstandingprincipalamountofthecompanyslongtermdebtasofSeptember30,2024,was10.61, and the Convertible Notes are convertible into 18,844,600 shares, excluding interest payments settled with shares[245] - The outstanding principal amount of the company's long-term debt as of September 30, 2024, was 200.0 million, excluding unamortized discounts and issuance costs of 4.3million[245]TaxandValuationIncometaxexpensefortheninemonthsendedSeptember30,2024,was4.3 million[245] Tax and Valuation - Income tax expense for the nine months ended September 30, 2024, was 22 million, a decrease of 56.9% compared to 51millioninthesameperiodin2023[196]TheeffectivetaxratefortheninemonthsendedSeptember30,2024,wasconsistentwiththepreviousyear,primarilyinfluencedbystateandlocaltaxes,permanentdifferences,anddiscreteitems[196]ThecompanymaintainsafullvaluationallowanceagainstitsdeferredtaxassetsasofSeptember30,2024,duetouncertaintyabouttheirrealization[197]TheCompanyperformedaquantitativegoodwillimpairmenttestasofSeptember30,2024,usingadiscountrateof12.051 million in the same period in 2023[196] - The effective tax rate for the nine months ended September 30, 2024, was consistent with the previous year, primarily influenced by state and local taxes, permanent differences, and discrete items[196] - The company maintains a full valuation allowance against its deferred tax assets as of September 30, 2024, due to uncertainty about their realization[197] - The Company performed a quantitative goodwill impairment test as of September 30, 2024, using a discount rate of 12.0%, and determined no impairment was necessary[241][242] - Goodwill impairment charge of 85.0 million was recognized for the nine months ended September 30, 2024, primarily due to a decrease in share price[192] Market Risk and Management - The company is exposed to market risk related to interest rates, primarily through fixed-rate long-term debt and revolving credit[245] - The company has policies and procedures in place to manage and mitigate market risks[247] National Defense Budget - The FY 2024 National Defense budget was set at 886billion,with886 billion, with 842 billion allocated to the DoD base budget[154] - The FY 2025 National Defense budget request is 895billion,with895 billion, with 850 billion proposed for the DoD base budget[155] Derivatives and Fair Value - Net decrease in fair value of derivatives was 1.3millionforthethreemonthsendedSeptember30,2024,comparedtoadecreaseof1.3 million for the three months ended September 30, 2024, compared to a decrease of 15.7 million in the same period in 2023, primarily due to the settlement of warrants[180] - Net increase in fair value of derivatives was 14.8millionfortheninemonthsendedSeptember30,2024,comparedtoadecreaseof14.8 million for the nine months ended September 30, 2024, compared to a decrease of 1.9 million in the same period in 2023, driven by fair value remeasurements of warrants[193] Free Cash Flow - Free cash flow for the nine months ended September 30, 2024, was (31.013)million,comparedto(31.013) million, compared to (20.979) million in the same period in 2023[201] Senior Revolver Covenants - The company was in compliance with the Senior Revolver covenants as of September 30, 2024, but is currently unable to draw on it due to Adjusted EBITDA requirements[214]